Cipher Pharmaceuticals Inc(CPHRF)

Description: Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.

---

Keywords: Medicine Organ Systems Rheumatoid Arthritis Arthritis Psoriasis Dermatology Lotion Ulcer Cholesterol Dystrophy Plaque Psoriasis Herpes Nail Sterol Sita Actinic Keratosis Cutaneous Conditions Keratosis Pharmaceuticals Segment Pole High Cholesterol Onychomycosis Various Medical Anti Acne Preparations Idex Ratos Claro Herpes Labialis Hyperkeratotic Actinic Keratosis Hyperpigmentation Isotretinoin Late Stage Products Mild/Moderate Onychomycosis Pharmaceutical Dermatology Recurrent Herpes Labialis Severe Nodular Acne

---

Home Page: www.cipherpharma.com

209 Oak Park Boulevard
Oakville, ON L6H 0M2
Canada
Phone: 905 602 5840

---

Officers

Exchange: PINK

Country: US

Currency: US Dollar ($)